Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT01063803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Study To Assess The Long-term Safety And Tolerability Of ATN-103 In Subjects With Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and will provide data on the long-term safety and tolerability of ATN-103 in subjects with rheumatoid arthritis.
Study identification
- NCT ID
- NCT01063803
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 266 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- Jan 31, 2012
- Completion
- Jan 31, 2012
- Last update posted
- Apr 10, 2016
2010 – 2012
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Birmingham | Alabama | 35216 | — |
| Investigational Site | Huntsville | Alabama | 35801 | — |
| Investigational Site | Peoria | Arizona | 85381 | — |
| Investigational Site | Riverside | California | 92501 | — |
| Investigational Site | Upland | California | 91786 | — |
| Investigational Site | Bridgeport | Connecticut | 06606 | — |
| Investigational Site | Newark | Delaware | 19713 | — |
| Investigational Site | Ocala | Florida | 34474 | — |
| Investigational Site | Port Orange | Florida | 32127 | — |
| Investigational Site | Vero Beach | Florida | 32960 | — |
| Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| Investigational Site | Frederick | Maryland | 21702 | — |
| Investigational Site | Lansing | Michigan | 48910 | — |
| Investigational Site | Freehold | New Jersey | 07728 | — |
| Investigational Site | Charlotte | North Carolina | 28210 | — |
| Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Investigational Site | Columbus | Ohio | 43213 | — |
| Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Investigational Site | Lake Oswego | Oregon | 97035 | — |
| Investigational Site | Columbia | South Carolina | 29204 | — |
| Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| Investigational Site | Nashville | Tennessee | 37205 | — |
| Investigational Site | Dallas | Texas | 75231 | — |
| Investigational Site | San Antonio | Texas | 78217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01063803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2016 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01063803 live on ClinicalTrials.gov.